Hagens Berman Reminds ADT Inc. (NYSE:ADT) Investors of the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
98
Hagens Berman Reminds ADT Inc. (NYSE:ADT) Investors of the July 20, 2018 IPO Securities Class Action Lead Plaintiff Deadline

SAN FRANCISCO, June 26, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ADT Inc. (NYSE: ADT ) of the July 20, 2018 ADT Lead Plaintiff deadline in the pending securities class action.  If you purchased or otherwise acquired securities of ADT pursuant or traceable to ADT’s January 2018 initial public offering (IPO) and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit:

https://www.hbsslaw.com/cases/ADT

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

ADT@hbsslaw.com .

On January 19, 2018, ADT conducted its IPO and issued approximately 105 million shares to investors at $14.00 per share.

By March 15, 2018, the Company reported a surprise adjusted loss for the fourth quarter of 2017.  MarketWatch  reported that day “[t]he number included a $690 million tax benefit from the December tax revamp” and “[e]xcluding special items, however, the company had a loss of 6 cents a share, while the FactSet consensus was for EPS of 10 cents.”

This news drove the price of ADT shares down $1.28, or about 12.5%, to close at $8.93 that day, which was approximately $5.07, or about 36%, lower than ADT’s IPO price.

“We’re focused on investors’ losses, Defendants’ apparently misleading boilerplate risk disclosures, and whether Defendants have complied with certain SEC guidelines about non-GAAP financial measures,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding ADT should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email ADT@hbsslaw.com .

About Hagens Berman Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country.  The Firm represents investors, whistleblowers, workers and consumers in complex litigation.   More about the firm and its successes can be found at www.hbsslaw.com .  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading